Up and running again

A Boston Scientific therapy helped Esther overcome cancer pain.

Read her story

Featured stories
Anatomical rendering of a heart, meant to represent atrial fibrillation (AFib).
Jul 31, 2026
Treating the dual challenges of AFib in one visit

Learn how atrial fibrillation and its related stroke risk can be addressed at the same time.

Jul 29, 2026
Interested in our Q2 2026 earnings?

Get some key highlights of our performance this quarter.

The eCoin System stimulates the tibial nerve to help address urge urinary incontinence symptoms.
Jul 1, 2026
Four things to know about our acquisition of Valencia Technologies

Learn how the acquisition expands treatment options for overactive bladder and urge urinary incontinence.

Read more stories

Press releases
Aug 10, 2026
Boston Scientific announces participation in Wells Fargo 21st Annual Healthcare Conference and conference call discussing third quarter 2026 results

Boston Scientific Corporation (NYSE: BSX) will participate in Wells Fargo's 21st Annual Healthcare Conference on Thursday, September 10, 2026. Mike Mahoney, chairman and chief executive officer,...

Jul 29, 2026
Boston Scientific announces results for second quarter 2026

Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.442 billion during the second quarter of 2026, growing 7.5 percent on a reported basis and 7.0 percent on an operational1 and...

May 19, 2026
FRACTURE IDE trial of the Boston Scientific SEISMIQ™ 4CE Coronary Intravascular Lithotripsy Catheter meets primary safety and effectiveness endpoints

Late-breaking data from global pivotal study achieved high rates of freedom from major adverse cardiac events and procedural success in patients with severe coronary artery disease

Read more press releases

In the news
Jul 20, 2026
How medical technology is redefining healthy aging
Wall Street Journal
As lifespans grow longer, targeted medical technology can help people live better, healthier lives—with fewer pills.
May 19, 2026
Boston Scientific posts positive data for coronary IVL catheter
MedTech Dive
Dr. Janar Sathananthan, president, Interventional Cardiology, discusses the FRACTURE IDE trial, which met its primary endpoints for the SEISMIQ™ 4CE Coronary IVL Catheter in severely calcified coronary disease. The result underscores Boston Scientific’s broader intravascular lithotripsy commercialization strategy and differentiated cardiology solutions.
May 12, 2026
How one woman found relief from bladder and bowl incontinence after 12 years
Parade
Karen Carlson’s incontinence kept her housebound for years despite various failed treatments. The Axonics™ Sacral Neuromodulation Therapy helped relieve her symptoms, restoring her active life.
Apr 28, 2026
Treating the twin burdens of AFib at the same time
Wall Street Journal
This sponsored article explores how physicians are helping patients living with atrial fibrillation address two health issues at the same time: irregular heart rhythms and stroke risk.

Read more news

2025 Impact Reporting

Advancing science for more innovative care, empowered people and a more sustainable future.

Learn about our impact

News alerts

Sign up to receive our press releases via email

Media contacts

Business and enterprise contacts for journalists

Media resources

Imagery and other resources

Top